Patent Term Extension Application for AVLAYAH® (tividenofusp alfa-eknm), Patent No. 10,870,837 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8225

Patent Term Extension Application for AVLAYAH® (tividenofusp alfa-eknm), Patent No. 10,870,837

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office to FDA CDER	Jul 30, 2026	--

CDER

Patent Term Extension Application for AVLAYAH

Covington & Burling LLP

Denali Therapeutics Inc.

(tividenofusp alfa-eknm)

Patent No. 10,870,837

OPEN